Peptide Decoding
New?New to peptides?Start here →
Decoding

Epitalon_Dosage, benefits & legal status

Also known as epithalon, epithalamin, AEDG

Published July 22, 2026 · Updated July 25, 2026

A longevity peptide taken in short courses for sleep and anti-aging.

Aging & sleepLongevity peptideResearch only
Common vial size10 mg
Dose5 up to 10 mg per day (start low, increase slowly)
Frequency10-20 day courses
RouteUnder the skin or into muscle
StatusResearch only
CycledCourses of 10 to 20 days, repeated two or three times a year

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

01

What is Epitalon?

Plain language first. The technical label stays, but it never stands alone.

Overview

It is taken in short courses for sleep and anti-aging. The idea is that it supports the body's internal clock. Strong human evidence is thin.

The technical version

Epitalon is a 4-amino-acid 'bioregulator' from the Russian Khavinson family, based on a natural pineal-gland peptide.

What it's used for

A longevity peptide taken in short courses for deeper sleep and anti-aging, thought to support the body's internal aging clock.

02

How does Epitalon work?

What it does in the body, and where.

Epitalon is four amino acids long, from the Russian bioregulator tradition, based on a peptide from the pineal gland. The claims made for it are large and the evidence behind them is unusually narrow.

  1. 01
    The proposal is that it activates telomerase
    Telomerase rebuilds the protective caps on the ends of your chromosomes, which shorten each time a cell divides.
  2. 02
    In cell studies, cells divided past their usual limit
    That is the finding the anti-aging claims rest on.
  3. 03
    The evidence traces to a single laboratory
    The telomerase and lifespan figures come from one Russian research group and have not been independently reproduced or published anywhere linkable. Treat them with more caution than anything else on this site.
Pathway
THE PEPTIDEEpitalonACTS ONTelomerase, which rebuilds DNA ca…RESULTCells divide past their normal limit

A schematic of the compound's mechanism, not a diagnostic image.

03

What else is it used for?

Each group carries its own evidence level.

Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

Telomeres and cell aging

Research only
  • Lab studyIn human cell cultures it raised telomerase activity about 2.4-fold and lengthened telomeres, letting cells divide past their normal limit.
  • Lab studyA 2025 independent study at a UK university confirmed telomere lengthening across several human cell lines.
Study

These figures trace to a single Russian laboratory and have not been independently published in a source we can link to. Treat them with more caution than the numbers elsewhere on this site.

Lifespan in animals

Research only
  • Animal studyFemale mice lived about 12.3% longer on average and had less lymphoma.
  • Animal studyIn aged monkeys and elderly people, a related pineal peptide restored the night-time melatonin rhythm.
  • No dataAlmost all of this comes from a single Russian laboratory, and turning on telomerase carries a theoretical cancer concern.
Study

These figures trace to a single Russian laboratory and have not been independently published in a source we can link to. Treat them with more caution than the numbers elsewhere on this site.

The published record

Research index

170

Records indexed for Epitalon

56 in humans, 33 of them original studies.

FDA: Nominated but withdrawn; previously category 2.

Browse the records

In animalsPro
In the labPro
ReviewsPro
Senior author sharePro

Counted from Europe PMC indexing, not read by a person. Human means indexed under humans, which includes reviews and work on human cells. Original studies exclude reviews and lab work on human cells.Last updated 12 September 2026.

Epitalon vial rendering
Compound field notes

At a glance

Four things to know about Epitalon

01

Evidence

Research only

02

Category

Longevity and energy

03

Common vial

10 mg

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

5 up to 10 mg per day (start low, increase slowly), 10-20 day courses. Courses of 10 to 20 days, repeated two or three times a yearCommunity practice

The course structure is how the Khavinson protocols specify it and how it is sold. No trial has compared course dosing against continuous use, or established what the gap between courses should be.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

Nothing published. A 2025 review notes that even basic physical characterisation of the peptide is limited, let alone how fast it clears.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: 5 up to 10 mg per day (start low, increase slowly)Community practice

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

Your draw

100 / 100 units
What it costs

Epitalon starts at $23.16 across 57 vendors, typically $1.70 – $7.70 per mg.

102 listings, last read Sep 6, 2026. Shipping and card fees are not included.

See all 102 listings →
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Epitalon keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • No formal contraindications established
  • Pregnancy

Stop and get help

These are emergencies. Seek care.
  • Signs of an allergic reaction
  • Anything unusual, given the thin data

Common effects

Expected, and usually mild.
  • No notable adverse events were reported in the available studies
  • Those studies are small, mostly Russian, largely not blinded, and not independently replicated, so safety is not robustly established

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Epitalon approved?

And where the numbers on this page come from.

No. Epitalon is not approved for any use, anywhere. It is sold labelled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin or into muscle
  • Checked
    August 2026

What has happened recently

On July 24, 2026, an FDA advisory committee voted by a narrow margin to recommend adding Epitalon to the list of substances pharmacies may compound. The FDA's own scientific reviewers had advised against it. The vote is advice, not a decision. HHS has to accept it and write formal rules first, so compounding Epitalon is still not legal today.

You can compare this against the whole library, or read how to check a seller.


Guides for this compound

Sources

  • FDA, Pharmacy Compounding Advisory Committee meeting, July 23-24, 2026(2026)
    FDA brought Epitalon before its Pharmacy Compounding Advisory Committee on 24 July 2026, to consider adding it to the 503A bulks list. The use evaluated was insomnia. That is the single most informative detail on this page for anyone considering this compound: not longevity, not telomeres, not ageing. Whoever nominated it put forward sleep. Two things about the page itself. It sets out the agenda and links FDA's briefing document for each substance, but it does not record how the vote went, so it tells you what was assessed rather than what was decided. And the page notes that advisory committees give non-binding recommendations which FDA generally follows but is not legally bound to, so even the vote would not be the final word.
  • FDA, bulk drug substances for compounding that may present significant safety risks(2026)
    FDA cites immunogenicity risk for certain routes from aggregation and peptide-related impurities, and states that it has not identified safety information for the proposed route, so it lacks sufficient information to know whether the drug would cause harm in people. As of the 22 April 2026 version of this page, the substance sits in the second table, headed bulk drug substances nominated but withdrawn, rather than in the live category 2 list. The nomination was withdrawn, which is not the same as being approved or cleared: FDA still publishes the safety language above, and no longer has a nomination in front of it to evaluate.

Last reviewed 14 August 2026

Beyond these, 170 records are indexed. Browse the records